News

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.
TMates Weightloss Semaglutide reviews reveal how users are losing weight with this telehealth prescription service—see if it ...
A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...
New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...
In today’s world, losing weight isn’t just about fitting into your old jeans—it’s about reclaiming your energy, confidence, ...
GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...
Glucagon-like peptide-1 (GLP-1) injections such as Wegovy (semaglutide) and Zepbound (tirzepatide) are the most effective weight-loss medications available today. Oral GLP-1 pills, such as ...
The UK's medicines regulator has launched a study to investigate the impact of these drugs following reports of people dying ...
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
Hundreds of people have reported problems with their pancreas linked to taking weight loss and diabetes jabs, prompting ...
Lifestyle therapy may not be enough to improve outcomes for patients with HF and obesity, but careful risk evaluation and ...